Dignitana
1,53 SEK -4,38%3 investorer følger denne virksomhed
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Omsætning
86,06 mio.
EBIT %
-17,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
DIGN
Daglig lav / høj pris
1,52 / 1,6
SEK
Markedsværdi
123,23 mio. SEK
Aktieomsætning
8,71 t SEK
Volumen
5,7 t
Seneste videoer
Finanskalender
Delårsrapport
21.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Agartha AB | 29,8 % | 29,8 % |
Swedbank Robur Microcap | 7,7 % | 7,7 % |
Försäkringsbolaget Avanza Pension | 7,2 % | 7,2 % |
UBS Financial Services INC | 5,2 % | 5,2 % |
Handelsbanken Microcap Sverige | 4,8 % | 4,8 % |
LQM Lundia AB | 3,3 % | 3,3 % |
Magbaleo | 2,3 % | 2,3 % |
FE Småbolag Sverige | 2,2 % | 2,2 % |
Technovobis AB | 2,2 % | 2,2 % |
ViserAlle indholdstyper
Dignitana AB: Dignitana Announces New CPT® Category I Codes from the American Medical Association for Mechanical Scalp Cooling
Dignitana AB announces PDMR transaction
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools